A representative example shows that αDG and EphA3 are expressed predominantly in regions, where mesenchymal tumour elements are present and expression is low or absent on the more differentiated GFAP+ glial tumour element (Fig. 2c). The gene discussed is EPHA3; the disease is glioma.